논문 상세보기
Background : Members of Amaryllidaceae family produce several alkaloids with unique structures and a variety of medicinal properties. Galantamine, in particular, is one of the alkaloids approved by the Food and Drug Administration (FDA), and the European Registration Bureau for treatment of Alzheimer’s disease. Lycoris radiata (L. radiata), belonging to the Amaryllidaceae family, is a bulbous plant containing galantamine, which exhibits selective and dominant acetylcholinesterase inhibition. In this study, metabolic profiling of L. radiata different organs was performed.
Methods and Results : Galantamine in root, bulb, and leaf of L.radiata analyzed by high performance liquid chromatography (HPLC). The amount of galantamine in leaf is about 1.07 ± 0.17 ㎎/g and it is the higher than bulb (0.88 ± 0.01 ㎎/g) and root (0.75 ± 0.01 ㎎/g). These results are statistically significant. Six phenolics are identified in L. radiata through high performance liquid chromatography. Total amounts of phenolics are the highest in bulb. Because plant secondary metabolism is closely related to plant primary metabolism, we used GC-TOF-MS on the levels of hydrophilic low-molecular-weight molecules in the L. radiata. A total of 41 metabolites, including sugars, amino acids, organic compounds, and phenolic acids, were identified and measured, and the resulting quantitative data were subjected to principal components analysis (PCA). The results of PCA of metabolic profiles clearly showed the lack of marked variance among different organs of L. radiata. Two principal components of the score plot explained 89.4% of the total variance (component 1, 51.86%; component 2, 37.54%). Component 1 resolved the separation of leaves from the other plant parts.
Conclusion : Amaryllidaceae family synthesize galantamine belonging to alkaloids. Particularly, in bulb of Lycoris radiata, galantamine contents are the highest level. Thus, bulb is very beneficial for Alzheimer’s disease because the galantamine is well known as treatment of dementia of Alzheimer type.
